<DOC>
	<DOCNO>NCT00016523</DOCNO>
	<brief_summary>This multicenter trial test whether inhaled nitric oxide would reduce death need oxygen preterm infant ( less 34 week gestational age ) severe lung disease .</brief_summary>
	<brief_title>Inhaled Nitric Oxide Preterm Infants With Severe Respiratory Failure</brief_title>
	<detailed_description>This multicenter , randomize , double-masked , control clinical trial evaluate efficacy inhale nitric oxide ( iNO ) treatment preterm infant respiratory failure secondary respiratory distress syndrome ( RDS ) , sepsis/pneumonia , aspiration syndrome , idiopathic pulmonary hypertension and/or suspect pulmonary hypoplasia . Infants follow death discharge home . The trial compare iNO therapy mock gas delivery control , otherwise incorporate conventional management strategy ( include treatment surfactant high frequency ventilation adjuncts iNO therapy ) . During initial dosing , iNO start 5 ppm could increase 10 ppm . If infant respond , study gas discontinue . For infant respond study gas , gradual weaning initiate . The total exposure study gas exceed 336 hour ( 14 day ) . Infants monitor sign toxicity . Medical neurodevelopmental outcome survive infant assess 18 22 month correct age mask , certified examiner .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Birth Weight</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>Inclusion Criteria Any infant birth weight 401 1500 gram &lt; 34 week gestational age OI ( mean Paw x FiO2 x 100/PaO2 ) &gt; 10 two consecutive blood gas least 30 minute apart , 12 hour apart . Infants &gt; 1500 gram &lt; 34 week gestational age enter Larger Preemie Pilot Study OI great equal 15 two consecutive blood gas least 30 minute apart , 12 hour apart . Infants require assist ventilation diagnosis RDS/HMD , pneumonia and/or sepsis , aspiration syndrome , idiopathic pulmonary hypertension , suspect pulmonary hypoplasia associate PROM and/or oligohydramnios . Greater equal 4 hour one dose surfactant . Less equal 120 hour age . All infant must indwell arterial line . Exclusion Criteria Any infant decision make provide full treatment ( e.g . chromosomal anomaly severe birth asphyxia ) . Known structural congenital heart disease , except patent ductus arteriosus atriallevel shunt . Infants major abnormality involve respiratory system congenital diaphragmatic hernia , tracheoesophageal fistula cystic fibrosis . Any bleeding diathesis consider clinically significant thrombocytopenia platelet count &lt; 50,000 . Prior enrollment conflict clinical trial Neonatal Network Surfactant CPAP trial.Inclusion Criteria</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>120 Hours</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>NICHD Neonatal Research Network</keyword>
	<keyword>Extremely Low Birth Weight ( ELBW )</keyword>
	<keyword>Very Low Birth Weight ( VLBW )</keyword>
	<keyword>Prematurity</keyword>
	<keyword>Inhaled nitric oxide</keyword>
	<keyword>Aspiration syndrome</keyword>
	<keyword>Idiopathic pulmonary hypertension</keyword>
	<keyword>Pulmonary hypoplasia</keyword>
</DOC>